Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS)

Background: Recent major randomized trials revealed the superiority of non-vitamin K antagonist oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) from 6 months to 2 years after percutaneous coronary intervention (PCI). However, whether NOAC monotherapy superiority over warfarin continues...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Yukio, Kawai, Hideki, Muramatsu, Takashi, Harada, Masahide, Takahashi, Hiroshi, Ishii, Hideki, Maekawa, Yuichiro, Ismail, Tevfik F., Amano, Tetsuya, Izawa, Hideo, Murohara, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Protocol Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726694/
https://www.ncbi.nlm.nih.gov/pubmed/36530841
http://dx.doi.org/10.1253/circrep.CR-22-0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726694/
https://www.ncbi.nlm.nih.gov/pubmed/36530841
http://dx.doi.org/10.1253/circrep.CR-22-0096

Ejemplares similares